In 2026, semaglutide is losing patent protection in many countries, and many companies are preparing to launch biosimilars of Ozempic (subcutaneous)
BPC-157's VEGFR2 engagement provides growth factor receptor signalling, while TB-500's actin-binding properties facilitate cytoskeletal remodelling necessary for cellular motility responses
Apr 222026Inorganic chemistry Bis(2-ethylhexyl) phthalate (DEHP) is an organic compound isolated from a number of microorganisms (e.g., bacteria and fungi), including Penicillium, Lactiplantibacillus plantarum BCH-1, Aspergillus parasiticus and Fusarium subglutinans
Learn gut-barrier repair the right way Empire Medical Training's Functional Gut Health course teaches barrier physiology, honest interpretation of functional testing, red-flag recognition, and evidence-graded repair within a root-cause framework taught by board-certified physicians including Dr
Great Im ready to order more